It was a pleasure talking about how our work in the lab can lead on to therapies in clinical trials, thanks @mndscotland.bsky.social for having me!

Very fun morning for the Gillingwater Lab, with @tomgillingwater.bsky.social, cheering on Giles Lomax for his (frankly insane) 435 mile capital-to-capital bike ride raising awareness for SMA UK More info on Giles' progress and how to support SMA UK: smauk.org.uk/cycling/capital-to-capital-cycle/

A gorgeous morning on the Mersey for Day 2 of #BNA2025! The plenary last night taught us the benefits of reading on the brain... Difficult to resist the books here but I suppose I should go If you're here, come and see my poster today on our latest work on therapy development in ALS 😊 Poster PT_052

High point of the week! Look at these lovely NMJs!!

Our new open access review published in @cp-trendsmolecmed.bsky.social provides an update on the exciting potential of targeting PGK1 as a therapeutic option for neurological diseases, including Parkinson’s disease and motor neuron diseases such as ALS: authors.elsevier.com/sd/article/S...

Proud to have been part of this advisory board. Thanks to @mndoddie5.bsky.social, and @dibbouk.bsky.social, for having Early Career Researchers on the panel, allowing us insight into how funding decisions are made, and good luck to the funded researchers in advancing our understanding of MND

I'm giving a lecture! I'll be talking about my work on preclinical development of a repurposed drug, see y'all there

Take a day's annual leave post-deadline ✔️ Fly south to avoid The Storm ✔️ Have a chill morning with the cats and some tennis ✔️

The Gillingwater Lab Christmas Party had a bit of a different start this year... with some curling! Unfortunately we weren't immediately Olympic standard, but we gave it our best shot @tomgillingwater.bsky.social